Position in LQDA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$14,657,347
+$1,572,117 QoQ
Shares Held
388,377
+2.4% QoQ
Ownership
0.437%
of shares outstanding
% of Portfolio
1.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Dec 31, 2023CallValue
$226,164
CallShares
18,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Pale Fire Capital SE holds $17,218,104 across 3 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (85.1% of the industry book) .
All Filings in LQDA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,657,347 | 388,377 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $13,085,230 | 379,392 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,473,995 | 240,721 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,067,822 | 85,700 | Shares | Defined | 2025-08-13 | |
| 2023-12-31 | $226,164 | 18,800 | Call | Defined | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||